Management of ischemic coronary disease in patients receiving chemotherapy: An uncharted clinical challenge

Bibhu Mohanty, Sudipta Mohanty, Yasin Hussain, Chandrasekhar Padmaraju, Sameer Aggarwal, Rebekah Gospin, Anthony F. Yu

Research output: Contribution to journalReview article

Abstract

Acute coronary syndrome (ACS) coinciding with active malignancy presents a unique clinical challenge given intersecting pathophysiology and treatment-related effects. There is little established clinical guidance on management strategies, rendering most treatment approaches anecdotal. We present a case highlighting the complexity of managing a patient being treated for malignancy who concurrently suffers from ACS. We then review the literature on co-management of ACS and malignancy, including reports of specific cancer therapies associated with ACS, unique features of clinical presentation and optimal use of dual antiplatelet therapy to minimize risks of bleeding and thrombosis. We also describe gaps in current literature, challenges in systematically studying the clinical intersection of these disease processes and propose alternative methodologies for further research.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalFuture Cardiology
Volume13
Issue number3
DOIs
StatePublished - May 1 2017
Externally publishedYes

Fingerprint

Acute Coronary Syndrome
Coronary Disease
Drug Therapy
Neoplasms
Second Primary Neoplasms
Thrombosis
Therapeutics
Hemorrhage
Research

Keywords

  • acute coronary syndrome
  • cancer
  • cardio-oncology
  • chemotherapy
  • ischemic heart disease

ASJC Scopus subject areas

  • Molecular Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Mohanty, B., Mohanty, S., Hussain, Y., Padmaraju, C., Aggarwal, S., Gospin, R., & Yu, A. F. (2017). Management of ischemic coronary disease in patients receiving chemotherapy: An uncharted clinical challenge. Future Cardiology, 13(3), 247-257. https://doi.org/10.2217/fca-2017-0002

Management of ischemic coronary disease in patients receiving chemotherapy : An uncharted clinical challenge. / Mohanty, Bibhu; Mohanty, Sudipta; Hussain, Yasin; Padmaraju, Chandrasekhar; Aggarwal, Sameer; Gospin, Rebekah; Yu, Anthony F.

In: Future Cardiology, Vol. 13, No. 3, 01.05.2017, p. 247-257.

Research output: Contribution to journalReview article

Mohanty, B, Mohanty, S, Hussain, Y, Padmaraju, C, Aggarwal, S, Gospin, R & Yu, AF 2017, 'Management of ischemic coronary disease in patients receiving chemotherapy: An uncharted clinical challenge', Future Cardiology, vol. 13, no. 3, pp. 247-257. https://doi.org/10.2217/fca-2017-0002
Mohanty, Bibhu ; Mohanty, Sudipta ; Hussain, Yasin ; Padmaraju, Chandrasekhar ; Aggarwal, Sameer ; Gospin, Rebekah ; Yu, Anthony F. / Management of ischemic coronary disease in patients receiving chemotherapy : An uncharted clinical challenge. In: Future Cardiology. 2017 ; Vol. 13, No. 3. pp. 247-257.
@article{81bf404a6d3e437aabb4bc0d3c7ae730,
title = "Management of ischemic coronary disease in patients receiving chemotherapy: An uncharted clinical challenge",
abstract = "Acute coronary syndrome (ACS) coinciding with active malignancy presents a unique clinical challenge given intersecting pathophysiology and treatment-related effects. There is little established clinical guidance on management strategies, rendering most treatment approaches anecdotal. We present a case highlighting the complexity of managing a patient being treated for malignancy who concurrently suffers from ACS. We then review the literature on co-management of ACS and malignancy, including reports of specific cancer therapies associated with ACS, unique features of clinical presentation and optimal use of dual antiplatelet therapy to minimize risks of bleeding and thrombosis. We also describe gaps in current literature, challenges in systematically studying the clinical intersection of these disease processes and propose alternative methodologies for further research.",
keywords = "acute coronary syndrome, cancer, cardio-oncology, chemotherapy, ischemic heart disease",
author = "Bibhu Mohanty and Sudipta Mohanty and Yasin Hussain and Chandrasekhar Padmaraju and Sameer Aggarwal and Rebekah Gospin and Yu, {Anthony F.}",
year = "2017",
month = "5",
day = "1",
doi = "10.2217/fca-2017-0002",
language = "English (US)",
volume = "13",
pages = "247--257",
journal = "Future Cardiology",
issn = "1479-6678",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Management of ischemic coronary disease in patients receiving chemotherapy

T2 - An uncharted clinical challenge

AU - Mohanty, Bibhu

AU - Mohanty, Sudipta

AU - Hussain, Yasin

AU - Padmaraju, Chandrasekhar

AU - Aggarwal, Sameer

AU - Gospin, Rebekah

AU - Yu, Anthony F.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Acute coronary syndrome (ACS) coinciding with active malignancy presents a unique clinical challenge given intersecting pathophysiology and treatment-related effects. There is little established clinical guidance on management strategies, rendering most treatment approaches anecdotal. We present a case highlighting the complexity of managing a patient being treated for malignancy who concurrently suffers from ACS. We then review the literature on co-management of ACS and malignancy, including reports of specific cancer therapies associated with ACS, unique features of clinical presentation and optimal use of dual antiplatelet therapy to minimize risks of bleeding and thrombosis. We also describe gaps in current literature, challenges in systematically studying the clinical intersection of these disease processes and propose alternative methodologies for further research.

AB - Acute coronary syndrome (ACS) coinciding with active malignancy presents a unique clinical challenge given intersecting pathophysiology and treatment-related effects. There is little established clinical guidance on management strategies, rendering most treatment approaches anecdotal. We present a case highlighting the complexity of managing a patient being treated for malignancy who concurrently suffers from ACS. We then review the literature on co-management of ACS and malignancy, including reports of specific cancer therapies associated with ACS, unique features of clinical presentation and optimal use of dual antiplatelet therapy to minimize risks of bleeding and thrombosis. We also describe gaps in current literature, challenges in systematically studying the clinical intersection of these disease processes and propose alternative methodologies for further research.

KW - acute coronary syndrome

KW - cancer

KW - cardio-oncology

KW - chemotherapy

KW - ischemic heart disease

UR - http://www.scopus.com/inward/record.url?scp=85020878139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020878139&partnerID=8YFLogxK

U2 - 10.2217/fca-2017-0002

DO - 10.2217/fca-2017-0002

M3 - Review article

C2 - 28570141

AN - SCOPUS:85020878139

VL - 13

SP - 247

EP - 257

JO - Future Cardiology

JF - Future Cardiology

SN - 1479-6678

IS - 3

ER -